Showing 3,301 - 3,320 results of 44,189 for search '"In Treatment"', query time: 0.15s Refine Results
  1. 3301
  2. 3302

    Importance of Artificial Intelligence-based Radiography in the Examination and Treatment of Patients with Subacromial Impingement Syndrome by Aytan Akhundova

    Published 2024-07-01
    “…Neck-shoulder syndrome is one of the most frequent causes of disability in the population, accounting for 18% of disability sheets. The treatment of pathologies attracts physicians of various specialties: orthopedic traumatologists, neurosurgeons, anesthesiologists, resuscitators, surgeons, neurologists, therapists, physiotherapists, and physical therapy physicians.…”
    Get full text
    Article
  3. 3303

    Fedratinib for the treatment of myelofibrosis: a critical appraisal of clinical trial and “real-world” data by Adrian Duek, Ilona Leviatan, Osnat Jarchowsky Dolberg, Martin H. Ellis

    Published 2025-01-01
    “…This may be due to the lack of a uniform definition of ruxolitinib failure, which may influence the timing of initiating fedratinib as a second-line treatment and result in a more prolonged exposure to ruxolitinib prior to intitaing fedratinib treatment. …”
    Get full text
    Article
  4. 3304
  5. 3305
  6. 3306
  7. 3307

    Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting by Michael Willis, Sandra Erntoft, Sofie Persson, Jenny M. Norlin, Ulf Persson

    Published 2014-10-01
    “…**Background:** Currently available topical treatments for actinic keratosis (AK) adversely affect patients’ quality of life because of long treatment durations and long-lasting local skin reactions (LSRs), which may result in poor treatment adherence and patient outcomes. …”
    Get full text
    Article
  8. 3308

    Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents by Robert B. Garoon, Robert E. Coffee, Lai Jiang, Christina Y. Weng, Petros E. Carvounis

    Published 2016-01-01
    “…To compare visual and anatomic outcomes of adjunct intravitreous (IVT) triamcinolone acetonide to antivascular endothelial growth factor (VEGF) injections to IVT anti-VEGF injections alone for center-involving diabetic macular edema (DME) in treatment-naïve eyes. Methods. Retrospective study of treatment-naïve eyes with center-involving DME. …”
    Get full text
    Article
  9. 3309

    Efficacy of Functional Re-Education as a Treatment for Infantile Flexible Flatfoot: Systematic Review by Cristina Molina-García, George Banwell, Francisco Álvarez-Salvago, Andrés Reinoso-Cobo, Clara Pujol-Fuentes, Jose Medina-Luque, Laura Ramos-Petersen

    Published 2024-12-01
    “…The reviewed literature recommends a minimum treatment duration of eight weeks. Conclusions: Functional re-education represents an effective conservative treatment option for flexible flatfoot in children, positioning it as the treatment of choice for this condition.…”
    Get full text
    Article
  10. 3310

    Insulin degludec 100 U/mL for treatment of spontaneous diabetes mellitus in dogs by Jocelyn Mott, Arnon Gal, Antonio Maria Tardo, Alisa Berg, Riley Claude, Alexis Hoelmer, Mei Lun Mui, Avin Arjoonsingh, Chen Gilor

    Published 2025-01-01
    “…Abstract Background The advantages of insulin degludec 100 U/mL (IDeg100) in the treatment of diabetes mellitus (DM) include consistent release, predictable glucose‐lowering effect, and minimal day‐to‐day variability. …”
    Get full text
    Article
  11. 3311
  12. 3312

    Ribitol and ribose treatments differentially affect metabolism of muscle tissue in FKRP mutant mice by Marcela P. Cataldi, Qi L. Lu

    Published 2025-01-01
    “…Further analysis is required to determine which metabolite is prudent to use for long-term daily treatment of dystroglycanopathies.…”
    Get full text
    Article
  13. 3313
  14. 3314
  15. 3315

    High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment by Halina Urbanska-Rys, Tadeusz Robak

    Published 2003-01-01
    “…MM patients in phase I (at diagnosis) had higher levels of endostatin (median, 69 ng/ml) than those in phase II (plateau phase after treatment) (median, 49 pg/ml; P=0.044). We did not find any statistical correlation between the level of endostatin and stage of MM according to the Durie and Salmon system. …”
    Get full text
    Article
  16. 3316

    Tooth loss and need for prosthetic treatment. El Carmen, Barinas State, Venezuela, 2018 by Yoel Gonzalez Beriau, Nadia Jover Capote

    Published 2021-08-01
    “…Timely prosthetic rehabilitation is the ideal treatment for this problem, as it allows the restoration of lost functions.…”
    Get full text
    Article
  17. 3317

    Clinical Efficacy of Subhypothermia in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy Combined with Myocardial Damage by XiaoPing Dang, XiaoJian Hu, Xun Jiang, WeiGuo Chen, YuanCui Meng, Qi Pan, Fen Yang

    Published 2022-01-01
    “…To investigate the efficacy of subhypothermia in the treatment of neonatal hypoxic-ischemic encephalopathy (HIE) combined with myocardial damage. …”
    Get full text
    Article
  18. 3318
  19. 3319

    Effect of Chemical Treatment on Physical, Mechanical and Thermal Properties of Ladies Finger Natural Fiber by S. I. Hossain, M. Hasan, Md. N. Hasan, A. Hassan

    Published 2013-01-01
    “…The tensile strength and Young's modulus values were found to be increased after chemical treatment. For both raw and chemically treated fibers, Young's modulus increased and tensile strength decreased with increase in span length. …”
    Get full text
    Article
  20. 3320

    Monocyte STAT1 phosphorylation and treatment response of JAK inhibitors in chronic nonbacterial osteomyelitis by Motoshi Sonoda, Keishiro Kinoshita, Nobutaka Harada, Sungyeon Park, Shunichi Adachi, Yutaro Yada, Katsuhide Eguchi, Toshifumi Fujiwara, Makiko Kido-Nakahara, Noriko Kinjo, Masataka Ishimura, Shouichi Ohga

    Published 2025-01-01
    “…In four intractable cases, pSTAT1 levels remained high despite conventional treatments but significantly decreased after initiating JAK inhibitors (p = 0.036). …”
    Get full text
    Article